Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Mevacor OTC Study Shows Cholesterol-Lowering Consistent With Rx Statins

This article was originally published in The Tan Sheet

Executive Summary

A cholesterol self-management program for OTC Mevacor was effective in deterring consumers from improperly purchasing the nonprescription version of the cholesterol-lowering drug, results from the CUSTOM actual-use study show
Advertisement

Related Content

Mevacor “Pharmacy Care” Tactic Insufficient To Ensure Compliance – Panel
Mevacor “Pharmacy Care” Tactic Insufficient To Ensure Compliance – Panel
Mevacor “Pharmacy Care” Tactic Insufficient To Ensure Compliance – Panel
FDAers Sink Mevacor OTC At Panel Meeting With Unflinching Critique
FDAers Sink Mevacor OTC At Panel Meeting With Unflinching Critique
FDAers Sink Mevacor OTC At Panel Meeting With Unflinching Critique
Mevacor meeting
OTC Statin Physician Follow-Up Label Comprehension Not Shown - FDA
Toll-Free Screening, Advice Service Would Enchance OTC Mevacor - Merck
Toll-Free Screening, Advice Service Would Enchance OTC Mevacor - Merck

Topics

Advertisement
UsernamePublicRestriction

Register

PS097543

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel